Roche Diagnostics International Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Roche Diagnostics International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012211
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd and is headquartered in Rotkreuz, Switzerland.

Roche Diagnostics International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Roche Diagnostics International Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Inotrem Enters into Research Agreement with Roche Diagnostics 11
Eli Lilly Enters into Agreement with Roche Diagnostics International 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Roche Diagnostics Enters Into Research Agreement With Vall d’Hebron Institute, CIBE-Rehd And Advanced Biological Labs 18
Acquisition 20
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Diagnostics International Ltd – Key Competitors 21
Roche Diagnostics International Ltd – Key Employees 22
Roche Diagnostics International Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Corporate Communications 25
Apr 13, 2016: Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Roche Diagnostics International Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Roche Diagnostics International Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Roche Diagnostics International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Inotrem Enters into Research Agreement with Roche Diagnostics 11
Eli Lilly Enters into Agreement with Roche Diagnostics International 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Roche Diagnostics Enters Into Research Agreement With Vall d’Hebron Institute, CIBE-Rehd And Advanced Biological Labs 18
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Diagnostics International Ltd, Key Competitors 21
Roche Diagnostics International Ltd, Key Employees 22
Roche Diagnostics International Ltd, Other Locations 23
Roche Diagnostics International Ltd, Subsidiaries 23
Roche Diagnostics International Ltd, Joint Venture 24

★海外企業調査レポート[Roche Diagnostics International Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kuraray Co., Ltd.:企業の戦略・SWOT・財務分析
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Freudenberg & Co. Kommanditgesellschaft:企業の戦略・SWOT・財務分析
    Freudenberg & Co. Kommanditgesellschaft - Strategy, SWOT and Corporate Finance Report Summary Freudenberg & Co. Kommanditgesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oragenics Inc (OGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Universal Power Group Inc (UPGI):企業の財務・戦略的SWOT分析
    Summary Universal Power Group Inc (UPG) a subsidiary of UPGI Holdings Inc, is a provider of electric mobility products. The company through its subsidiaries supplies and distributes batteries and related power accessories. It offers sealed lead-acid batteries, ap series batteries, hc series batterie …
  • NovaMedica LLC-製薬・医療分野:企業M&A・提携分析
    Summary NovaMedica LLC is a drug company that offers gastroenterology and ophthalmology products. The company offers pharmaceutical and other medical products such as diagnostic equipment, medical devices and technologies designed to provide a solution for range of interrelated problems. It provides …
  • The Seibels Bruce Group Inc:企業の戦略・SWOT・財務分析
    The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Apex Oil Company, Inc.:企業の戦略・SWOT・財務分析
    Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. …
  • Bristow Group Inc:企業の戦略・SWOT・財務情報
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nice Ltd (NICE):企業の財務・戦略的SWOT分析
    Nice Ltd (NICE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Genocea Biosciences Inc (GNCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Genocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tech …
  • PT Bio Farma:製薬・医療:M&Aディール及び事業提携情報
    Summary PT Bio Farma (Bio Farma) is a manufacturer and supplier of vaccines, sera, and biological and diagnostics products. The company offers products such as DTP-hep B vaccine, DTP vaccine, DT vaccine, TT vaccine, polio vaccine, measles vaccine and BCG vaccine. It also offers biott vaccine for the …
  • OncoSec Medical Inc (ONCS):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • NTT DOCOMO Inc:企業の戦略・SWOT・財務分析
    NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Linde AG (LIN):医療機器:M&Aディール及び事業提携情報
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineeri …
  • Aegis Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aegis Therapeutics LLC (Aegis Therapeutics) is a drug-delivery and drug-formulation technologies company that commercializes drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. The company offers Intravail, …
  • Associated Petroleum Products Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Associated Petroleum Products Inc (APP), a subsidiary of World Fuel Services Corp is an oil and gas company that offers petroleum products. The company provides products such as commercial fuel, aviation fuel, fuels, heating oil, lube oil, fuel additives, propane, marine lubricants and equip …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆